EP Patent

EP3495363B1 — Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect

Assigned to Shionogi and Co Ltd · Expires 2023-08-23 · 3y expired

What this patent protects

Patent listed against cariprazine-hydrochloride.

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3495363B1
Jurisdiction: EP
Classification: —
Expires: 2023-08-23
Drug substance claim: No
Drug product claim: No
Assignee: Shionogi and Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.